Business

Business

Search: 8,725건

Economic Talk Show

SOOP Implements Major Price Hike for Subscription Services to Bolster Profitability
Kia to Resume Operations at Gwangju Plant 3 Following Suspension Due to Fatal Workplace Accident
Personal Information Protection Commission to Take Firm Action on SK Telecom Data Breach
Court Rules Kakao Mobility's AI-Based Dispatch Algorithm Not Unfair Practice
POSCO Group Launches First LNG Carrier to Expand Global Energy Business
Kakao Mobility Wins Lawsuit Over Fair Trade Commission’s Penalty for Alleged Favoritism in Ride-Hailing
Kakao Spins Off Daum Portal into New Subsidiary ‘Daum Ready Co., Ltd.’ After 11 Years
KFTC Conducts On-Site Investigation into Coupang Over Alleged Bundling of Coupang Play in WOW Membership
종근당이 노바티스에 기술수출한 차세대 항암제 후보물질 'CKD-510'이 미국에서 임상시험에 본격 돌입한다. 이에 따라 종근당은 첫 기술료를 수령하게 됐다. 종근당은 노바티스에 기술수출한 CKD-510의 단계별 마일스톤 달성에 따라 기술료를 수령할 예정이라고 22일 밝혔다. 마일스톤은 약 69억원(500만달러) 수준이다. 이번 마일스톤은 노바티스가 CKD-510에 대해 미국 식품의약국(FDA)에 첫 번째 임상시험계획서(IND)를 제출한 데
Wemade Files Formal Complaint Against DAXA Exchanges with Korea’s Fair Trade Commission
Court Dismisses Injunction Filed by Asiana Airlines Pilots to Block Cargo Business Transfer to Air Incheon
KRAFTON India Makes Strategic Investment in Indian Hyperlocal Community App 'Shuru'
SPC Samlip Shares Decline for Three Consecutive Days Following Worker Fatality at Siheung Plant
Hanwha Aerospace Raises First Issue Price in Rights Offering to KRW 684,000 per Share Amid Strong Stock Performance
Korea Exchange Requests Samsung Biologics to Clarify Spin-Off Rumors
Shilla Duty Free and Shinsegae DF File for Rent Adjustment with Incheon Airport Amid Mounting Losses
KHNP Appeals Czech Court's Injunction to Resume Nuclear Power Plant Contract Signing
Personal Data from SK Telecom Hacking Incident Suspected to Have Been Transferred to Singapore
T'way Air Postpones Shareholder Meeting Again Amid Regulatory Delay in Daemyung Sono Group Acquisition
Nintendo Selects Samsung to Manufacture Custom Chip for Next-Gen 'Switch 2' Console

SNS